Neurodegeneration across stages of cognitive decline in Parkinson disease. - Wikidata - awgldk - TriplyDB

Neurodegeneration across stages of cognitive decline in Parkinson disease.

Neurodegeneration across stages of cognitive decline in Parkinson disease.

http://www.wikidata.org/entity/Q34096712

about

Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease The Interaction between Obstructive Sleep Apnea and Parkinson's Disease: Possible Mechanisms and Implications for Cognitive Function Mild cognitive impairment in Parkinson's disease Nitric Oxide and the Biological Cascades Underlying Increased Neurogenesis, Enhanced Learning Ability, and Academic Ability as an Effect of Increased Bouts of Physical Activity Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.Default mode network differences between rigidity- and tremor-predominant Parkinson's disease Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.Structural Imaging and Parkinson's Disease: Moving Toward Quantitative Markers of Disease Progression.Mapping cortical atrophy in Parkinson's disease patients with dementia.Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's disease Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson's disease: a cross-sectional study.Initial cognitive decline is associated with cortical thinning in early Parkinson disease.Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study Differential patterns of planning impairments in Parkinson's disease and sub-clinical signs of dementia? A latent-class model-based approach Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease.Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease.Intracerebroventricular transplanted bone marrow stem cells survive and migrate into the brain of rats with Parkinson's disease Improving response inhibition in Parkinson's disease with atomoxetine.Imaging changes associated with cognitive abnormalities in Parkinson's disease Tracking Parkinson's Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.Structural MRI Correlates of Episodic Memory Processes in Parkinson's Disease Without Mild Cognitive Impairment.Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.Relationship between cognitive impairment and white-matter alteration in Parkinson's disease with dementia: tract-based spatial statistics and tract-specific analysis.Cortical thinning is associated with disease stages and dementia in Parkinson's disease Role of α-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus.Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson's disease.Grey matter changes in cognitively impaired Parkinson's disease patients.Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease.Mild cognitive impairment in Parkinson disease: heterogenous mechanisms.The neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging.Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia.Neurobiology of cognitive impairment in Parkinson's disease.Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease?Mild cognitive impairment in Parkinson's disease: a review of current concepts.Neural and behavioral substrates of subtypes of Parkinson's disease.

P2860

Q26748709-996B39C0-5C4D-477C-893F-5A40988F1152 Q26778246-600B834D-5BB6-4226-9724-4F3A988E9FD3 Q27007766-15DC0CC7-62AC-449A-AC60-C6E7C0295BE1 Q27687739-9611DD41-698C-4CBF-99AA-2A3A6EEA51F1 Q30611520-73AE0DCC-85CD-41F7-8EBE-6A4B2A5BD2F5 Q30843485-5D96FD78-609E-4A29-B308-0C15E12A40A6 Q31097119-EC6432F3-0B00-44CE-A76B-0D74E209EAAB Q31105385-938CADDC-CE46-4336-A858-A124EEEC96D0 Q33599010-1A080413-B700-4448-BF78-08A9D57D7F8B Q33658107-803C9B32-7273-4294-8FE0-2B2CA12D2D50 Q33917300-185DA5FD-9B2C-4CE7-BAF5-8412C5CDD1A6 Q33927210-5563416D-F2CD-43FD-99BF-5E46B7A7E561 Q34174901-D655D50B-640C-4107-AAB1-7DC6F150D6EA Q34310403-7F3B684D-F0C4-4EA4-A401-F18E9B7DCA17 Q34566376-B1523E1C-FBE9-4D7E-9F41-ED01C72A128F Q35036220-B595202C-CFAE-4350-AA79-02815A198E13 Q35123779-015CD955-E11C-45DC-9E5E-052C8061A569 Q35264006-8BFBEE5C-9B3A-4E04-B81A-155A3F044E1B Q35797763-67DA146C-FD28-4218-B47A-02EC5C8B71FC Q35880760-8A63758C-75F6-4E5C-A348-69C09E3E2424 Q36175217-4D562D9A-6915-4971-A45D-585126321935 Q36179280-F471580C-23C1-4F2D-89C6-247AB72C43EA Q36351574-C5120AD0-8C2F-4DF9-ADC3-E71040D3745A Q36581514-B16F265F-F31B-4ED1-98B3-078083218A08 Q36592670-B324F977-1C6A-41F6-B01C-A23CBDBBE662 Q36656691-968419C4-85AA-40E3-95A8-EBF4CBE70F7F Q36877488-54F0C272-DCBA-40D6-BB43-6164B95B32CD Q36907033-4F6533F6-0430-426D-BABF-F71DDB4665D3 Q37030350-095B3E60-56C0-40DC-B8FD-A32E242BF5E2 Q37128532-020F3B59-9992-4B3C-A61F-544666231906 Q37276021-BCB00FC6-3815-4EF6-B6D7-584ADC0EF751 Q37499581-C4AB4131-E7D2-4593-B9B3-21F20EA13179 Q37647815-75282CC3-FD08-452F-836E-EB1DAFAE8765 Q37986572-ACDF8CFF-8A7C-4158-8825-B508AF10EB7A Q38049561-5181898B-F579-4F99-A921-470B2F58D810 Q38051969-011B279E-0D8D-4474-AAD8-FFCCA4823E43 Q38067143-D42086D0-A064-4BAD-9129-1A0D23FFCB53 Q38085592-2009598F-8392-4CD6-ABA9-C963AFDD1F8D Q38128309-AFAB48B2-9705-4A0A-B8DD-0B38BE796415 Q38176606-D407E7DA-D52D-45D3-8FAF-69B89018335D

P2860

Neurodegeneration across stages of cognitive decline in Parkinson disease.

http://www.wikidata.org/entity/Q34096712

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Neurodegeneration across stages of cognitive decline in Parkinson disease.

@ast

Neurodegeneration across stages of cognitive decline in Parkinson disease.

@en

Neurodegeneration across stages of cognitive decline in Parkinson disease.

@nl

type

label

Neurodegeneration across stages of cognitive decline in Parkinson disease.

@ast

Neurodegeneration across stages of cognitive decline in Parkinson disease.

@en

Neurodegeneration across stages of cognitive decline in Parkinson disease.

@nl

prefLabel

Neurodegeneration across stages of cognitive decline in Parkinson disease.

@ast

Neurodegeneration across stages of cognitive decline in Parkinson disease.

@en

Neurodegeneration across stages of cognitive decline in Parkinson disease.

@nl

P1433

Q34096712-6D738B6F-8BFF-41CA-8423-AEF05C1EB6D6

P1476

Q34096712-82ECF552-CF54-4301-9E6F-AD60EA51DAA4

P2093

Q34096712-09AE0A5C-2384-4D0D-A63C-F8BA15A16AD6

Q34096712-119BD534-1FDD-47EF-9710-18262A4F95B1

Q34096712-157448F5-5178-4858-8BA2-912FFE6C84A2

Q34096712-2D476097-671D-47B3-A9E8-963253FC5878

Q34096712-5E2461B8-B45B-474E-9EEB-A47E6197E83E

Q34096712-8A461E95-6D2D-4A8D-8F91-CA826286AA57

Q34096712-8C44929B-29E4-44CE-BE92-6E2A0CA144A9

Q34096712-D887CC36-E7F3-4570-968B-3689492012F0

P2860

Q34096712-0531C4B8-3D20-4655-8636-C7CD5DBC6A6A

Q34096712-12FD25EC-D178-45C7-BAC7-4A6BB820F864

Q34096712-13C83FEB-CEC2-4905-9221-367D4895F16F

Q34096712-1BDFCA34-0C16-4007-85F8-290A3318107D

Q34096712-1E2AE9AB-6480-43C0-905B-6AB1D8468EF5

Q34096712-29ACD963-8F92-40C0-8B02-DE31A5ABA788

Q34096712-2C3B8F5E-BA2B-4ACE-AFFC-54937250822F

Q34096712-2EE53FE8-1DE3-42B7-A7D0-BD9D9B65D489

Q34096712-3A1D2F0C-11DC-4C0C-822C-B912AED12A30

Q34096712-3A5FA776-9CF2-49A9-90DA-83FCD314013C

P304

Q34096712-88B863D8-483E-4144-BDA0-ED365CEF862A

P31

Q34096712-9B87AAD4-5DC2-44F6-8FB6-CD2676C807AA

P356

Q34096712-82C4EA7F-A53E-4AA9-95AC-DD1806087091

P433

Q34096712-21B7E34F-300A-4247-B8BC-EE2BFC23D560

P478

Q34096712-B6CADE34-1035-4BE0-A2B7-22B6A62051FC

P50

Q34096712-20ED289A-7252-4750-9501-274CEE0565A2

Q34096712-85D0BBFB-F602-45E9-8A4D-E853A5C1FAB5

P577

Q34096712-F55C4B86-5DF7-4BBC-8994-0AC1A3D15FE5

P5875

Q34096712-AE66AA5D-AEDF-430F-A705-FA574E074B92

P698

Q34096712-0BC5A945-F959-4A87-ACD7-9B1265463FDF

P921

Q34096712-24A81D43-F698-45B6-B9D1-82927E11F1ED

P932

Q34096712-799AFAF9-C8A3-479C-8D48-06D568C25C40

P356

ARCHNEUROL.2011.725

P1433

P1476

Neurodegeneration across stages of cognitive decline in Parkinson disease.

@en

P2093

Andrew D Siderowf

http://www.w3.org/2001/XMLSchema#string

Christopher M Clark

http://www.w3.org/2001/XMLSchema#string

David A Wolk

http://www.w3.org/2001/XMLSchema#string

Deepthi Koka

http://www.w3.org/2001/XMLSchema#string

Jimit Doshi

http://www.w3.org/2001/XMLSchema#string

John E Duda

http://www.w3.org/2001/XMLSchema#string

Paul J Moberg

http://www.w3.org/2001/XMLSchema#string

Sharon X Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease

Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

MRI and cognitive impairment in Parkinson's disease.

The MoCA: well-suited screen for cognitive impairment in Parkinson disease.

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification

Association between cognition and function in patients with Parkinson disease with and without dementia.

Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia

Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment

P304

1562-1568

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUROL.2011.725

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

Christos Davatzikos

Daniel Weintraub

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51868995

http://www.w3.org/2001/XMLSchema#string

P698

22159053

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3290902

http://www.w3.org/2001/XMLSchema#string